Electrochemical insights into alkaline hexacyanoferrate-mediated oxidation of creatinine: Evidence for cyanide release, Iron–Oxo formation, and Iron nanoparticle growth
Electrochemistry Communications · 2026-09 · 190 · 108231
DOI: 10.1016/j.elecom.2026.108231 ↗Kurz gefasst
Fachartikel in der Zeitschrift Electrochemistry Communications, 2026-09. Verfasst von Jayaprakash Meena und 3 weiteren Autor:innen. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Engineering Research Board, Department of Science and Technology, Ministry of Science and Technology, India, Science for Equity, Empowerment and Development Division.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Science and Engineering Research Board
- Department of Science and Technology, Ministry of Science and Technology, India
- Science for Equity, Empowerment and Development Division
Zitieren
APA
Meena, J., Madhuvallika, S., Santhakumar, K., & Kumar, A. S. (2026). Electrochemical insights into alkaline hexacyanoferrate-mediated oxidation of creatinine: Evidence for cyanide release, Iron–Oxo formation, and Iron nanoparticle growth. Electrochemistry Communications, 190, 108231. https://doi.org/10.1016/j.elecom.2026.108231
Vancouver
Meena J, Madhuvallika S, Santhakumar K, Kumar AS. Electrochemical insights into alkaline hexacyanoferrate-mediated oxidation of creatinine: Evidence for cyanide release, Iron–Oxo formation, and Iron nanoparticle growth. Electrochemistry Communications. 2026;190:108231. doi:10.1016/j.elecom.2026.108231
BibTeX
@article{Meena2026,
author = {Meena, Jayaprakash and Madhuvallika, Sreekonda and Santhakumar, K. and Kumar, Annamalai Senthil},
title = {Electrochemical insights into alkaline hexacyanoferrate-mediated oxidation of creatinine: Evidence for cyanide release, Iron–Oxo formation, and Iron nanoparticle growth},
journal = {Electrochemistry Communications},
year = {2026},
volume = {190},
pages = {108231},
doi = {10.1016/j.elecom.2026.108231}
}
EUVIMED